(Q45825932)

English

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

scientific article published on 2 August 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Per thor Straten

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Tania Køllgaard

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Per Kongsted

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Lisa Sengeløv

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

2 August 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

63

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1177-1187

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25085000%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

https://scigraph.springernature.com/pub.10.1007/s00262-014-1591-2

0 references

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

On the armament and appearances of human myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Regulation of immune responses by L-arginine metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Regulatory T cells in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Regulation of T cell receptor CD3zeta chain expression by L-arginine

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Pretreatment frequency of circulating IL-17+CD4+T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

IL-6/IL-6R as a potential key signaling pathway in prostate cancer development

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1591-2

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45825932&oldid=1856214491"